Skip to main content

Day: December 11, 2023

HeartCore Implements New Function to Enhance its Market Leading CMS Platform

NEW YORK and TOKYO, Dec. 11, 2023 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, announced that it has developed and integrated a new “Builder for Creating Admin Screens” functionality into its market leading content management systems (“CMS”) platform, which allows users to create original submission screens within the platform. HeartCore’s latest “Builder for Creating Admin Screens” function allows users of the CMS platform to effortlessly design and customize their own personalized submission screens tailored specifically to individual needs and preferences. Developing a submission screen in many CMS platforms often requires the involvement and expertise of external production entities or proficient webmasters,...

Continue reading

Arbor Realty Trust Announces an Increase of its Share Repurchase Program to $150 Million

UNIONDALE, N.Y., Dec. 11, 2023 (GLOBE NEWSWIRE) — Arbor Realty Trust, Inc. (NYSE: ABR), today announced that its Board of Directors has approved an increase to the Company’s share repurchase program authorizing the Company to repurchase up to $150 million of its outstanding common stock. The share repurchase program allows shares to be repurchased at management’s discretion from time to time in the open market, through privately negotiated transactions or otherwise in compliance with Rule 10b-18 and Rule 10b5-1 under the Securities Exchange Act of 1934. The share repurchase program also permits the Company to establish Rule 10b5-1 trading plans to repurchase its outstanding shares at times when it might otherwise be prevented from doing so. This share repurchase program does not obligate the Company to acquire any particular...

Continue reading

BIGG Digital Assets Co-Founder Shone Anstey Returns as a Strategic Advisor; Update on Digital Asset Due Diligence Audit Service Offering

VANCOUVER, British Columbia, Dec. 11, 2023 (GLOBE NEWSWIRE) — BIGG Digital Assets Inc. (“BIGG” or the “Company”) (CSE: BIGG; OTCQX: BBKCF; WKN: A2PS9W), a leading innovator in the digital assets space and owner of Netcoins, and Blockchain Intelligence Group and TerraZero is pleased to announce the addition of Due Diligence Audits to its arsenal of digital asset investigations and compliance services. This strategic move comes in response to the proliferate demand for digital asset auditing solutions arising after the discovery of the multi-billion dollar FTX fraud in November 2022. There is vast business potential, and a regulatory need, within the digital asset market for auditing and due diligence services. BIGG recently completed a proof of reserves and platform due diligence audit for Wonderfi Technologies Inc., Canada’s largest...

Continue reading

JIN MEDICAL INTERNATIONAL LTD. Secures RMB66 Million in Orders for Innovative Micro-Hyperbaric Oxygen Chamber Equipment

Changzhou City, China, Dec. 11, 2023 (GLOBE NEWSWIRE) — JIN MEDICAL INTERNATIONAL LTD. (the “Company” or “JinMed”) (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced that it has secured orders of RMB 66 million (approximately $9.18 million USD) of their innovative Micro-Hyperbaric Oxygen Chamber equipment (S-type and M-type) from Conlo Industrial Development (Shanghai) CO., LTD. (“Conlo”). Building on the successful launches of its MINI micro-hyperbaric oxygen chamber and hydrogen generation machine products in this September, JinMed has recently unveiled S-type (accommodating 2-3 people) and M-type (accommodating 4-6 people) micro-hyperbaric oxygen chambers. Engineered with precision and designed for optimal...

Continue reading

IMUNON Appoints Dr. Sebastien Hazard as Chief Medical Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Accomplished pharmaceutical and biotechnology executive to lead IMUNON’s clinical programs in ovarian cancer and infectious diseases LAWRENCEVILLE, N.J., Dec. 11, 2023 (GLOBE NEWSWIRE) — IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage drug-development company focused on developing non-viral DNA-mediated immunotherapy and next-generation vaccines, announces the appointment of Sebastien Hazard, M.D. as Chief Medical Officer, effective December 11, 2023. Dr. Hazard brings to IMUNON a strong background in building and leading clinical development organizations, most recently at Bicycle Therapeutics. He will report to IMUNON’s President and Chief Executive Officer, Dr. Corinne Le Goff. “We are delighted to welcome Dr. Hazard to IMUNON to lead this important function,” said Dr. Le Goff. “The timing is right to add a CMO to advance the...

Continue reading

C-Bond Systems’ Patriot Glass Solutions Subsidiary Receives Follow-On Purchase Order for Large Oil Company, Increasing Size of Job to Approximately $500,000

Patriot Glass Solutions is installing C-Bond BRS (ballistic-resistant system) at oil company’s Houston offices to prevent damage and injury from gunfire SAN ANTONIO, Texas, Dec. 11, 2023 (GLOBE NEWSWIRE) — C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a developer and marketer of glass strengthening solutions for enhanced safety, announced today that its Patriot Glass Solutions subsidiary has received a follow-on purchase order for a large oil company for approximately $170,000, increasing the size of the job to approximately $500,000. The purchase order is for C-Bond BRS (ballistic-resistant system), which is being installed at the oil company’s offices in Houston. The Company previously announced, in conjunction with the receipt of other purchase orders, the initial purchase order for this customer in October. The initial...

Continue reading

KUSTOM ENTERTAINMENT NAMES ERIK DAHL CHIEF FINANCIAL OFFICER

Industry veteran adds expertise, momentum to growing Digital Ally company KANSAS CITY, Dec. 11, 2023 (GLOBE NEWSWIRE) — Digital Ally, Inc. (NASDAQ: DGLY) – Kustom Entertainment, Inc. (“Kustom Entertainment”), a premier live event marketing and concert production company and subsidiary of Digital Ally Inc. (“Digital Ally”) (Nasdaq: DGLY), has tapped Kansas City-native Erik Dahl as its new Chief Financial Officer (the “CFO”). The appointment, effective November 20, 2023, puts Mr. Dahl at the helm of Kustom Entertainment’s financial operations, including FP&A, strategy, accounting, procurement, tax, and human resources. “Erik’s experience, enthusiasm and agility make him a great addition to our leadership team,” Kustom Entertainment CEO Stanton E. Ross said. “Momentum is building again in live entertainment....

Continue reading

Safety Shot Sells Out on First Day Online at www.DrinkSafetyShot.com

Safety Shot, Inc.Safety Shot Sells Out on First Day Online at www.DrinkSafetyShot.comCompany had successful West Coast Launch December 7, 2023 Company ramping up manufacturing and supply chain to meet higher than expected demand, 2 million cans to be ready by mid-January. Preorders now available at www.DrinkSafetyShot.comJUPITER, FL, Dec. 11, 2023 (GLOBE NEWSWIRE) — Safety Shot, Inc. (Nasdaq: SHOT) today announced that Safety Shot, the first patented beverage that helps people feel better faster by reducing blood alcohol content and boosting clarity, sold out on its first day of availability on the Company’s direct-to-consumer website www.DrinkSafetyShot.com on December 7. The Company had previously announced that on November 30th, Safety Shot also sold out within hours of being available on Amazon. By mid-January 2024,...

Continue reading

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

   Data showed favorable safety profile, complete response rate and durability in the treatment of patients with relapsed or refractory indolent B-cell Non-Hodgkin Lymphoma 100% of patients with follicular lymphoma achieved a complete response; no occurrence of CRS above grade 1 and no ICANS of any grade Complete responses observed in patients previously treated with CD19-targeted CAR T-cell therapy Outpatient administration found to be feasible WORCESTER, Mass., Dec. 11, 2023 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for difficult-to-treat cancers and rare genetic diseases, today announced updated encouraging safety and efficacy data from Mustang’s multicenter Phase...

Continue reading

Brilliant Earth Group, Inc. Announces $20 Million Share Repurchase Program

Program Reflects Company’s Healthy Balance Sheet and Commitment to Delivering Shareholder Value SAN FRANCISCO, Dec. 11, 2023 (GLOBE NEWSWIRE) — Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (Nasdaq: BRLT), an industry-disrupting global leader in ethically sourced fine jewelry, announced today that its Board of Directors has approved a share repurchase program with authorization to repurchase up to $20 million in shares of its Class A common stock. “As a growth company, we are keenly focused on seizing value creation opportunities, including when we see an attractive buying opportunity for our common stock,” said Beth Gerstein, co-Founder and Chief Executive Officer of the Company. “Our strong balance sheet provides an opportunity for us to execute this share repurchase program and to realize the significant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.